• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

  • in AJO · Oncology
  • — 17 Jan, 2007
Ian Smith

IAN SMITH, Royal Marsden Hospital, London

REFERENCE: Lancet 369:29
Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast cancer has been published recently in the Lancet. Ian Smith gave Peter Goodwin three-year follow up results from the Herceptin Adjuvant (HERA) Study conducted among 3,000 women in Europe.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Share

Tags: breastcancerHER2trastuzumab

You may also like...

  • Oropharyngeal Carcinoma: Better Outlook From Human Papilloma Virus-Directed Therapies— Different Patient Characteristics, New Therapeutic Opportunities 15 Apr, 2009
  • Farbice André MD, PhD, from the Institut Gustave Roussy in Villejuif, France Deep Genomic Profiling in Breast Cancer Promises to Improve Outcomes 26 Mar, 2015
  • Cora Sternberg Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too 24 Mar, 2013
  • Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer 11 Feb, 2014

Leave a Reply Cancel reply

  • Previous story Audio Journal of Medicine: Circulating Markers Herald Onset of Preeclampsia
  • Next story Audio Journal of Global Health Issues: Microfinance Helps Cut Domestic Violence in Rural South Africa
  • News

    • First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
    • MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014
    • First enterovirus 71 vaccines effective against hand, foot and mouth diseaseFebruary 28, 2014
  • Home
  • Oncology
  • AJO
  • Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

© COPYRIGHT 2013 AUDIOMEDICA.COM.